Search

everythinglearnresearchcommunity

for

Search:↓

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Midazolam impairs learning and memory by increasing neurosteroids through specific receptor activation.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

The study successfully identified the structure of finasteride.

RY-023, a specific drug, can improve early stage memory learning without affecting general activity in rats, but it's less effective for later learning stages and doesn't impact memory recall.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

Researchers made two new compounds that could be used for medicine.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

Rizatriptan benzoate-loaded dissolving microneedles are effective and convenient for treating acute migraines.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

A new compound shows promise as a topical treatment for hair loss.

Certain medications like antipsychotics and some antidepressants increase the risk of falls in older patients.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

A new method was developed to make finasteride for treating hair loss.

Compound 1 showed promising anticancer activity.

Diphenyl cresyl phosphate has low toxicity but can harm the liver, kidneys, adrenal glands, and testicles at high doses.

Midazolam reduces PTSD-like behavior in rats by acting on specific brain receptors.

Newly made nicotinamide compounds could potentially treat cancer.

MT-DADMe-ImmA can selectively kill head and neck cancer cells without harming normal cells.

The document concludes that specific methods for making diazine-based drugs can lead to high yields and are important for creating effective treatments for various diseases.

Three specific 4-azasteroid-2-oximes showed strong enzyme inhibition, but less than finasteride.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

The research shows that hydrogen bonds greatly affect the crystal structure of a Finasteride derivative.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

New method makes important drug ingredients more easily without needing extra purification steps.

Near-infrared probes can safely and effectively image cysteine protease activity for disease diagnosis.